News
18h
Clinical Trials Arena on MSNAscletis begins dosing in Phase IIa trial of ASC30 for obesity treatmentIn April 2025, Ascletis reported early weight loss results from a Phase Ib trial of ASC30. "Ascletis begins dosing in Phase ...
From dermatitis to acne, know skin conditions that can be triggered by obesity. Doctor shares prevention tips to follow.
Insurance companies should not drag their feet. They must take meaningful steps to ensure that obesity treatment is easily ...
A clinical guidance from the American College of Cardiology Solution Set Oversight Committee states that pharmacotherapy may ...
Endoscopic gastric remodeling reduced GERD symptoms and dependence on proton pump inhibitors in patients with obesity, according to a new study.
Slashing health care support for low-income Californians isn’t just a budget decision, it is a public health crisis in the ...
9d
News-Medical.Net on MSNOnce-monthly obesity injection shows double-digit weight loss in major clinical trialResearchers found that once-monthly maridebart cafraglutide led to substantial weight loss and improved glycemic control in ...
A separate Prime analysis, however, of year-over-year claims data for Wegovy and Zepbound only found an improvement in ...
Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results